en

PRODUCT DETAIL

CellCept 250 mg kapsuly

Code 55682
MA number EU/1/96/005/003
Product Form: cps dur 300x250 mg (blis.PVC/Alu)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA06 Mycophenolic acid
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 13.05.1997
SmPC + PL: European Medicines Agency's database
Dokument: DHPC_Cellcept_risk of teratogenity_FINAL.pdf  
Dokument: DHPC_CellCept_12 12 2014.pdf  
Dokument: CellCept PRCA DHCP 18 05 09.pdf  
Safety feature Yes
Data update: 15.06.2018
eu-flag.png sk-flag.png